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Objective To evaluate the eff  ect of hyaluronidase in lumbar interlaminar epidural injection (LIEI) for low back 
pain and sciatica. 
Method Sixty-one patients suff  ering from severe low back pain and sciatica were randomly allocated into three 
groups. Group T (n=18, mean duration of illness: 2.12±1.16 months) received lumbar interlaminar epidural 
injection (LIEI) with 2 ml triamcinolone (40 mg/ml) and 5 ml bupivacaine (0.25%). Group H (n=16, mean duration 
of illness: 2.05±1.12 months) received LIEI with 1,500 IU hyaluronidase and 5 ml bupivacaine (0.25%). Group TH 
(n=27, mean duration of illness: 2.16±1.65 months) received LIEI with 1,500 IU hyaluronidase, 2 ml triamcinolone 
(40 mg/ml), and 5 ml bupivacaine (0.25%). Th  e  eff  ects were evaluated using the Visual Analogue Scale (VAS) and 
Oswestry Disability Index (ODI) at preinjection and 2 weeks, 4 weeks, and 8 weeks after LIEI. 
Results Pain improved in all groups after 2 weeks (p<0.05). After 8 weeks, there was no signifi  cant diff  erence in VAS 
improvement among the 3 groups. However, pain improved in 70.4% of Group TH compared with preinjection, 
in contrast to 44.4% of Group T and 31.3% of Group H. Th   e ODI improved signifi  cantly only in Group TH after 8 
weeks (p<0.05).
Conclusion LIEI with triamcinolone and hyaluronidase is more effective for reducing pain after 8 weeks than 
injection with triamcinolone or hyaluronidase alone. 
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surgical therapy (such as discectomy), as well as epidural 
injections that can be implemented between conservative 
treatment and surgical therapy. Epidural injections are 
an important treatment method that can relieve initial 
symptoms and reduce the need for surgery.
2
  It has been revealed that local injections of steroids 
and local anesthetics can relieve both the pain caused 
by mechanical pressure
3 and the pain caused by 
infl  ammatory responses resulting from TNF-α
4 and NO2
5 
existing in nucleus pulposus cells; as such, steroids and 
local anesthetics are used as major drugs for epidural 
injections. 
  However, McLain et al.
6 reported that when epidural 
steroid injections had been implemented with a 
INTRODUCTION
  
  Low back pain and lower extremity radiating pain are 
conditions suffered by 80% of the entire population at 
least once in their lifetime,
1 and treatments for these 
conditions include conservative treatments such as 
bed rest, drug treatment, and physical therapy, and 
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transforaminal approach, among the 50-75% of subjects 
who showed temporary relief of symptoms, only 25-57% 
showed long-term pain relief and thus, while steroid 
administration was effective in some patients with 
neuropathy, the duration of the eff  ects was quite limited.
  Hyaluronidase is a drug that was tested to improve the 
eff  ect of epidural injections using steroids and to extend 
the duration of the eff  ect. Hyaluronidase is characterized 
by its actions to remove barriers between tissues by 
hydrolyzing glucosaminic bonds between hyaluronic 
acid, a major intercellular material, and connective 
tissues to dissolve the bonds and relieve fibroplasia in 
tissues. It is also known that hyaluronidase acts to relieve 
swelling and edema in tissues.
7 Hyaluronidase is being 
used in the areas of ophthalmology and anesthesiology to 
remove scar tissue and to increase the tissue permeability 
of injections.
  The use of hyaluronidase should be avoided in 
patients who show hypersensitivity reactions to bovine 
proteins, in areas of infection or swelling, in patients 
with congenital heart defects, in venous congestion 
patients, and in patients with genetic problems such as 
galactose intolerance or lactase deficiency. It has been 
reported that if hyaluronidase is used in accordance 
with recommended methods of use, there are no serious 
adverse eff  ects.
  In Korea, results have been published regarding studies 
that verified the effects of hyaluronidase on failed back 
surgery syndrome patients and cervical or lumbar 
herniated intervertebral disc patients, but the studies 
had limitations, such as small numbers of patients in 
subject groups, lack of a control group, or failure to adjust 
factors that could aff  ect patients’ treatment eff  ects, such 
as combination treatments after the intervention.
7,8
  In this respect, to determine whether there are additio-
nal effects of hyaluronidase in epidural injections 
administered to herniated intervertebral disc patients, 
we conducted a prospective randomized controlled study 
on a total of 101 patients.
MATERIALS AND METHODS 
Study subjects
  Among patients who visited the hospital between 
January 2010 and April 2010 with low back pain and lower 
extremity radiating pain as chief complaints, 101 patients 
were randomly divided into 3 groups who apparently had 
low back pain or lower extremity radiating pain resulting 
from lumbar herniated intervertebral discs based on 
clinical findings, the results of physical examinations, 
and the results of magnetic resonance imaging. Patients 
who had undergone surgery in the past and those with 
spinal stenosis or a facet joint syndrome were excluded 
from the study.
Study method
  The 101 patients were randomly divided into 3 groups 
named T, H, and TH, based on the types of drugs 
to be injected. The epidural injections, which were 
implemented using the interlaminar approach, were 
administered after having the patients take a lateral 
decubitus position with a posture of fl  exed neck, pelvis, 
and knees. The skin and subcutaneous tissues were 
anesthetized by injecting 1-2 ml of 1% lidocaine between 
the #4 and #5 spinous processes of the lumbar vertebrae, 
and a 20-gauge Tuohy needle was inserted 2-3 cm so 
as to enter the interspinal ligament. Then, a syringe 
containing air was attached to the needle, and the needle 
was slowly pushed forward, 1-2 mm at a time, until the 
absence of resistance was felt. Th   e location of the needle 
was identified by injecting 2 ml of a non-ionic contrast 
medium and seeing the upward diff  usion of the contrast 
medium in the form of a thin line.
  When the needle was identifi  ed at an epidural location, 
injections were administered as follows: group T 
(n=30), received a local anesthetic and a steroid (2 ml 
of triamcinolone, 40 mg/ml and 5 ml of bupivacaine, 
0.25%); group H (n=32), received a local anesthetic and 
hyaluronidase (1,500 IU of hyaluronidase and 5 ml of 
bupivacaine, 0.25%); and group TH (n=39), received a 
local anesthetic, a steroid, and hyaluronidase (1,500 IU 
of hyaluronidase, 2 ml of triamcinolone, 40 mg/ml, and 5 
ml of bupivacaine, 0.25%).
  The effects of the intervention were evaluated by 
measuring Visual Analogue Scales (VAS) and Oswestry 
Disability Indexes (ODI) before the intervention and 
at 2 weeks, 4 weeks, and 8 weeks after the intervention 
to determine whether hyaluronidase was effective for 
long-term reductions of pain. Th   e ratios of patients who 
showed 50% or larger reductions in pain based on VAS 
values at 2 weeks and 4 weeks after the intervention were 
calculated by group.HA in Lumbar Epidural Injection 
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  To control factors that could affect the patients’ 
treatment effects, the same series of oral drugs was 
prescribed to the patients who participated in the study 
for 2 weeks after their first visit to the hospital. No 
physical treatment was implemented after the injection 
treatment. Fifteen patients who received combination 
treatments such as physical therapy and Chinese 
medicine treatments at other medical institutions, 6 
patients who could not take drugs due to gastrointestinal 
disorders or hypersensitivity reactions to drugs, and 19 
patients who had not followed up were excluded from the 
study.
Statistics 
  Statistical analysis was conducted using the SPSS 14.0 
statistical program for Windows. Analysis of variance 
(ANOVA) was used to compare degrees of change in VAS 
and ODI among the three groups before the intervention, 
and at 2, 4, and 8 weeks after the intervention. Cases 
which p-values were ≤0.05 were judged to be statistically 
signifi  cant.
RESULTS 
  Of the 101 patients, 16 patients were excluded from 
the study 2 weeks after the intervention and, of the 
remaining 85 patients, 24 were excluded from the 
study 8 weeks after the intervention; thus, a total of 61 
patients participated in the study until 8 weeks after the 
intervention. Except for male/female sex ratios, there 
were no signifi  cant diff  erences in age, height, and causal 
diseases among the three groups (Table 1). No signifi  cant 
difference was observed among the 3 groups in either 
VAS or ODI before the intervention (p>0.05) (Table 2). At 
2 weeks after the intervention, 78.3% of group T, 73.1% 
of group H, and 88.9% of group TH answered that their 
pain was relieved. The degree of favorable change in 
VAS at 2, 4, and 8 weeks after the intervention compared 
to the values before the intervention was shown to be 
highest in group TH, followed by group T, and group H in 
order of precedence (Fig. 1), but the differences among 
the 3 groups were not statistically significant (Table 3). 
Regarding ODI, improvements were observed in all 3 
groups and, whereas there was no signifi  cant diff  erence 
in degree of change among the 3 groups at 2 and 4 weeks 
after the intervention, signifi  cantly larger improvements 
were observed in group TH compared to groups T and 
Table 1. Demographic Data
T (n=18) H (n=16) TH (n=27)
Age (years) 61.07 61.25 60.47
Sex (male/female) 8/10 7/9 11/16
Weight (kg) 63.27 64.48 61.56
Height (cm) 164.14 164.20 164.56
Diagnosis
Lumbar HIVD 16 15 25
Lumbar HIVD with 
spondylolisthesis
  2   1   2
HIVD: Herniated intervertebral disc, T: Triamcinolone 
and bupivacaine, H: Hyaluronidase and bupivacaine, 
TH: Triamcinolone, hyaluronidase, and bupivacaine
Table 2. Comparison of Mean Visual Analog Scale and Oswestry Disability Index in Each Group 
TH T H
Visual analog scale
Pre-injection   6.77±2.47   6.53±1.74   6.90±2.06
After 2 weeks   4.40±2.32   5.42±2.12   4.61±2.13
After 4 weeks   3.95±2.12   4.68±2.24   4.18±2.30
After 8 weeks   3.95±2.44   5.00±2.83   3.40±2.09
Oswestry disability index
Pre-injection   23.79±10.81 18.00±7.89 21.56±9.04
After 2 weeks   17.88±10.29 15.08±6.82 16.88±7.94
After 4 weeks 16.61±9.29 15.47±8.57 15.28±8.33
After 8 weeks   16.05±10.86   16.88±11.84 12.77±7.18
T: Triamcinolone and bupivacaine, H: Hyaluronidase and bupivacaine, TH: Triamcinolone, hyaluronidase, and 
bupivacaine.Sang Beom Kim, et al.
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H at 8 weeks after the intervention (p<0.05) (Fig. 2). Th  e 
ratios of patients who showed at least 50% reduction 
in pain based on VAS values at 2 and 8 weeks after the 
intervention were calculated by group and, based on the 
results (Table 4), it was found that pain was reduced in 
33.3% of group T, 12.4% of group H, and at least 50% of 
group TH at 2 weeks after the intervention. However, at 8 
weeks after the intervention, pain was reduced by at least 
50% compared to before the intervention in 44.4% of 
group T, 31.3% of group H, and 70.4% of group TH (Fig. 3).
DISCUSSION
  The intent of this study was to determine if epidural 
injections supplemented with hyaluronidase were 
beneficial for improving pain relief effects and for 
extending the duration of pain relief. Based on the results 
of this study, it can be seen that epidural injections 
of steroids and local anesthetics supplemented with 
hyaluronidase could maintain pain relief and reduce 
inconveniences in daily life for relatively long periods of 
time, thereby increasing the eff  ects of epidural injections. 
  For low back pain and lower extremity radiating pain 
resulting from herniated intervertebral discs, epidural 
injections using steroid and local anesthetic mixed 
solutions are a treatment recommended as a stage prior 
to surgery, because its eff  ects were proved in cases where 
symptoms were not relieved, even after a long period 
of conservative treatment. However, to examine the 
durability of treatment eff  ects, Carette et al.
9 and Wilson-
Wilson-MacDonald et al.
10 conducted a randomized 
Table 3. Comparison of the Mean Decrease of VAS and 
ODI among T group, H group, and TH group
T H TH p-value
Mean decrease of VAS
After 2 weeks -1.76 -0.85 -2.28   0.065
After 4 weeks -2.41 -1.71 -2.89   2.298
After 8 weeks -3.26 -1.68 -3.48   0.070
Mean decrease of ODI
After 2 weeks -6.16 -4.62 -3.64   0.067
After 4 weeks -7.73 -4.88 -6.80 0.30
After 8 weeks -6.68 -1.75   -8.26*   0.005
VAS: Visual Analog Scale, ODI: Oswestry Disability Index, 
T: Triamcinolone and bupivacaine, H: Hyaluronidase 
and bupivacaine, TH: Triamcinolone, hyaluronidase, and 
bupivacaine
*p<0.05
Table 4. Patients with > 50% Pain Relief as Measured by 
VAS
THT H
After 2 weeks 6/18 (33.3%) 2/16 (12.4%)   7/27 (25.9%)
After 4 weeks 8/18 (44.4%) 5/16 (31.3%) 19/27 (70.4%)
VAS: Visual Analog Scale, T: Triamcinolone and Bupi  va-
caine, H: Hyaluronidase and Bupivacaine, TH: Triam-
cinolone, Hyaluronidase, and Bupivacaine
Fig. 1. Comparison of mean change of Visual Analogue 
Scale. T: Triamcinolone and Bupivacaine, H: Hyaluronidase 
and Bupivacaine, TH: Triamcinolone, Hyaluronidase, and 
Bupivacaine
Fig. 2. Comparison of mean change of Oswestry Disability 
Index. T: Triamcinolone and Bupivacaine, H: Hyaluronidase 
and Bupivacaine, TH: Triamcinolone, Hyaluronidase, and 
Bupivacaine.
*p<0.05HA in Lumbar Epidural Injection 
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controlled study on patients with radiculopathy and 
reported that although steroids were eff  ective in relieving 
early stage pain, they did not have long-term benefi  ts.
  Carette et al.
9 published a report indicating that signi-
fi  cant pain relief and improved functions were observed 
in an experimental group injected with 8 ml of a steroid 
and normal salinemixed solution, compared to a 
control group that received epidural injections of 1 ml of 
normal saline; but based on the results of calculations of 
accumulated probabilities of undergoing back surgery 
by 12 months later, there was no significant difference 
between the two groups. In addition, Buchner et al.,
11 
who compared the effects of epidural injections with 
the effects of physical therapy, reported that although 
significant pain relief was observed in a group that 
received epidural injections compared to a control group 
that received physical therapy during the initial 2 weeks, 
there was no substantial improvement in mid-long-term 
followup observations thereafter. As such, regarding 
the eff  ects of epidural injections, it is suggested that the 
reason steroids show eff  ects during initial short periods, 
but the duration of the effects is limited, is because 
steroids cannot greatly affect the processes of fibrocyte 
proliferation, collagen deposition, and cicatrization 
around nerve roots occurring in the latter stages of 
infl  ammatory processes.
8
  Hyaluronidase is a drug that has been tested to over-
come the limited duration and eff  ects of existing epidural 
injections. In Korea, Lee et al.
7 reported good results 
when they injected hyaluronidase along with steroids in 
10 patients who were suffering from pain due to tissue 
synechia around nerve roots as part of failed back surgery 
syndromes,
12 because hyaluronidase was known to 
remove barriers between tissues and reduce fibroplasia 
in tissues, as well as reduce swelling and edema. Jo et al.
8 
reported that during transforaminal epidural injections, 
they evaluated pain relief for 6 months in a group injected 
with steroids and local anesthetics only, and in another 
group injected with a mixed solution containing steroid, 
local anesthetic, and hyaluronidase. Results showed that 
pain relief continued in a few more patients in the latter 
group, although the differences were not statistically 
signifi  cant.
  Previous studies had limitations for evaluating the 
additional eff  ects of hyaluronidase in epidural injections 
due to the absence of a control group; failure to adjust 
factors that could aff  ect patients’ treatment eff  ects such 
as combination treatments after the intervention or 
diff  erences in oral drugs; and small numbers of patients 
in subject groups. In this study, a total of 61 patients 
with low back pain or lower extremity radiating pain 
resulting from herniated intervertebral discs were 
divided into 3 groups: a group injected with steroids 
and local anesthetics (group T); a group injected with 
hyaluronidase and local anesthetics (group H); and 
a group injected with steroid, local anesthetic, and 
hyaluronidase (group TH) to evaluate not only the 
additional effects of hyaluronidase but also its singular 
eff  ects in epidural injections. 
  In this study, the ratios of patients who showed at 
least 50% VAS reduction after the intervention were 
determined and, based on the results, clear differences 
were observed at 8 weeks after the intervention. 
The ratios of groups T and H were 44.4% and 31.3% 
Fig. 3. Pain relief > 50% as measured by Visual Analogue Scale. T: Triamcinolone and Bupivacaine, H: Hyaluronidase and 
Bupivacaine, TH: Triamcinolone, Hyaluronidase, and BupivacaineSang Beom Kim, et al.
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respectively, while the ratio of group TH was 70.4%. 
Significant improvements in ODI were also observed in 
group TH as compared to groups T and H 8 weeks after 
intervention. That is to say, in the early stage after the 
intervention, similar degrees of pain relief were observed 
in groups T and TH due to the infl  ammation suppressing 
effects of steroids but, as time went on, group TH 
showed superior effects compared to group T in the 
extension of the duration of pain relief and the degree of 
subjective inconvenience. Th   is is believed to be because 
hyaluronidase not only suppressed fi  broplasia, collagen 
deposition, and cicatrization to contribute to pain 
relief, but also enhanced steroid permeation to bring 
added synergistic eff  ects for pain relief. Th   ese results are 
diff  erent from the results of a study by Devulder et al.,
13 
which indicated that in 1-, 3-, and 6-month followup 
observations after selective epidural nerve root sleeve 
injections in patients with failed back surgery syndromes, 
there was no signifi  cant diff  erence among the 3 groups, 
and that the diff  erences are attributable to diff  erences in 
the composition of lumbar part diseases of experimental 
subject groups and the injection methods.
  A comparison of group T and group H showed that 
not only the average values of VAS improved at 2, 4, 
and 8 weeks after the intervention, but also the ratios 
of patients with at least 50% pain relief at 2 and 8 weeks 
after the intervention were higher in group T. This 
suggests that the degree of contribution to the eff  ects of 
epidural injections for pain relief resulting from steroids’ 
suppression of inflammation was higher than that of 
hyaluronidase’s suppression of inflammatory responses 
in the latter stage.
  Limitations of this study include the fact that, although 
we attempted to determine the long-term effects 
of hyaluronidase when only drug treatments were 
implemented after injections, the patients’ compliance 
declined over time, and thus the results were observed 
only up to 8 weeks. Also, local anesthetics were included 
in all 3 groups and thus there were diffi   culties in judging 
the singular effects of hyaluronidase. In addition, 
although it was determined that VAS and ODI were not 
statistically different among the three groups before 
the intervention, the patients were not classified by the 
degree of herniated intervertebral disc. We propose 
that the eff  ects of hyaluronidase can be more accurately 
evaluated if future studies on patients with failed back 
surgery syndromes using diverse injection methods 
are conducted after classifying patients by the degree 
of herniated intervertebral disc, and by including local 
anesthetic and hyaluronidase single-administration 
groups.
CONCLUSION
  We observed the additional effects of hyaluronidase 
in lumbar epidural injections on 61 patients with low 
back pain or lower extremity radiating pain resulting 
from herniated intervertebral disc. At the early stage (2 
weeks after the intervention), similar degrees of pain 
relief were observed in group T and group TH due to the 
inflammation suppressing effects of steroids. However, 
as time progressed, group TH showed superior effects 
compared to group T for the extension of the duration of 
pain relief and the degree of subjective inconvenience. 
Therefore, it is suggested that epidural injections 
using hyaluronidase and steroid mixed solutions are 
more effective than single steroid therapy not only 
for extending the duration of pain relief, but also for 
reducing patients’ sense of inconvenience. 
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